PF-6687859

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePF-6687859
Drug Alias NamePF-06687859Quinazoline-495PF-6687859RG-3039RG3039
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionScavenger mRNA-decapping enzyme DcpS inhibitors
TargetsScavenger mRNA-decapping enzyme DcpS
Therapy Area/IndicationsMuscular Atrophy, Spinal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesRepligen
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRepligen
Active IndicationsN/A
Inactive IndicationsMuscular Atrophy, Spinal

Other Information

ATC CodeN/A
Related LinksN/A